6
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Cytokine and costimulatory factor-encoding plasmids as adjuvants for DNA vaccination.

      Methods in molecular medicine

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The induction of a potent and long-lasting immunity is one of the most important elements to consider in developing an effective vaccine. DNA vaccines induce markedly stronger CD8(+) cytotoxic T lymphocyte (CTL) activity than do traditional peptide vaccines through their particular mechanism of antigen presentation mediated by MHC class I molecules. Induction of CTL specific to pathogenic viruses is thought to provide a reliable means of protecting a host from infection and halting disease progression, as these cells can directly recognize and lyse infected cells. However, in most of the early studies showing induction of pathogen-specific CTL, antigen-encoding immunogenic DNA alone was used and DNA vectors encoding immunomodulating molecules were not considered. It now appears that various types of immunomodulatory molecules such as cytokines (IL-1 [1], IL-2 [2], IL-12 [3], IFN-γ [4], IL-7 [5-7], and GM-CSF [8,9]), chemokines (TCA-3 [10], RANTES [11], MIP-1 [11]), and costimulatory molecules (CD40L [12], B7-1 [13] and B7-2 [14]) could enhance or modify the specific immune responses elicited by DNA immunization (see Table 1). Table 1 Summary of Effects of Cytokines after Conventional Vaccination and of Expression Plasmids following DNA Immunization Immunomodulatory Molecules Effect Ref. A. Cytokine proteins IL-1 Antibody (Ab) ↑ (23,24) IL-2 Ab ↑ (2,25,26) IL-12 TH1(DTH) ↑ (3) IFN-γ Ab, DTH ↑ (4,25,27) GM-CSF Ab ↑ (28,29) B. Expression plasmids IL-12 CTL ↑(i.m. and i.n.) (15,21,22,30) DTH ↑(i.m. and i.n.) (5,21) Ab →(i.m. and i.n.) (15,22) GM-CSF Ab ↑(i.m.) (9,18,22 CTL ↑(i.m.) (18) (3)H-TdR uptake ↑(i.m.) (9) TCA3 CTL ↑(i.m.) (31) DTH ↑(i.m.) (31) Ab →(i.m.) (31) B7-1 CTL →(i.m.) (19) DTH →(i.m.) (19) Ab →(i.m.) (19) B7-2 CTL ↑(i.m.) (19) DTH ↑(i.m.) (19) Ab →(i.m.) (19) CD40(L) Ab →(i.m.) (A. Ihata et al., Unpublished data) CTL ↑(i.m.) (A. Ihata et al., Unpublished data) i.m., intramuscular administration; i.n., intranasal administration; Ab, antibody production; DTH, delayed type hypersensitivity; (3)H-TdR, incorporation of (3)H-Thymidine; ↑, activated immune response.

          Related collections

          Author and article information

          Journal
          21374321
          10.1385/1-59259-688-6:197

          Comments

          Comment on this article